부산대학교 도서관

File DM; Department of Medical Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC.; Abdou Y; Department of Medical Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, Chapel Hill, NC. Electronic address: Yara_Abdou@med.unc.edu.; Force J; Department of Medicine, Duke University, Durham, NC; Duke Cancer Institute, Durham, NC.; Moore DT; Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Anders CK; Department of Medicine, Duke University, Durham, NC; Duke Cancer Institute, Durham, NC.; Reeder-Hayes K; Department of Medical Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Carey LA; Department of Medical Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Muss HB; Department of Medical Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Perou CM; Department of Medical Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Department of Genetics, The University of North Carolina, Chapel Hill, NC.; Marcom PK; Department of Medicine, Duke University, Durham, NC; Duke Cancer Institute, Durham, NC.; Dees EC; Department of Medical Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

Tarantino P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Tayob N; Harvard Medical School, Boston, MA.; Division of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Oncology Data Science Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Dang C; Memorial Sloan Kettering Cancer Center, New York, NY.; Yardley DA; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.; Isakoff SJ; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA.; Valero V; MD Anderson Cancer Center, Houston, TX.; Faggen M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Mulvey T; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA.; Bose R; Washington University School of Medicine, St Louis, MO.; Weckstein D; New Hampshire Oncology Hematology, Manchester, NH.; Wolff AC; Johns Hopkins Sidney Kimmel Cancer Center, Washington, DC.; Reeder-Hayes K; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Rugo HS; University of California, San Francisco, CA.; Ramaswamy B; Ohio State University Comprehensive Cancer Center, Columbus, OH.; Zuckerman D; St Luke's Mountain States Tumor Institute, Boise, ID.; Hart L; Wake Forest Baptist Health, Winston-Salem, NC.; Gadi VK; University of Illinois Cancer Center, Chicago, IL.; Constantine M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cheng K; North Shore-LIJ Cancer Institute, Lake Success, NY.; Garrett AM; Northern Light Cancer Care, Brewer, ME.; Marcom PK; Duke University School of Medicine, Durham, NC.; Albain K; Loyola University Medical Center, Maywood, IL.; DeFusco P; Hartford Healthcare Cancer Institute, Hartford, CT.; Tung N; Harvard Medical School, Boston, MA.; Beth Israel Deaconess Medical Center, Boston, MA.; Ardman B; Lowell General Hospital, Lowell, MA.; Nanda R; UChicago Medicine, Chicago, IL.; Jankowitz RC; Perelman Center for Advanced Medicine, Philadelphia, PA.; Rimawi M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX.; Abramson V; Vanderbilt-Ingram Cancer Center, Nashville, TN.; Pohlmann PR; MD Anderson Cancer Center, Houston, TX.; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.; Van Poznak C; Rogel Cancer Center, University of Michigan, Ann Arbor, MI.; Forero-Torres A; Kirklin UAB Hematology Oncology, Birmingham, AL.; Liu MC; Natera, Inc, Austin, TX.; Ruddy KJ; Mayo Clinic, Rochester, NY.; Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; DeMeo M; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Dell'Orto P; IEO European Institute of Oncology, IRCCS, Milan, Italy.; Russo L; IEO European Institute of Oncology, IRCCS, Milan, Italy.; Krause E; PathAI, Boston, MA.; Newhouse DJ; NanoString Technologies, Inc, Boston, MA.; Kurt BB; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Mittendorf EA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA.; Schneider B; Indiana University School of Medicine, Indianapolis, IN.; Prat A; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Winer EP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT.; Krop IE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT.; Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Lenz L; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA.; Neff C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA.; Solimeno C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA.; Cogan ES; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA.; Abramson VG; Vanderbilt University Medical Center, Nashville, TN, USA.; Boughey JC; Mayo Clinic, Rochester, MN, USA.; Falkson C; University of Rochester Medical Center, Rochester, NY, USA.; Goetz MP; Mayo Clinic, Rochester, MN, USA.; Ford JM; Stanford University School of Medicine, Stanford, CA, USA.; Gradishar WJ; Northwestern University, Chicago, IL, USA.; Jankowitz RC; University of Pennsylvania, Philadelphia, PA, USA.; Kaklamani VG; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.; Marcom PK; Duke University, Durham, NC, USA.; Richardson AL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Storniolo AM; Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA.; Tung NM; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Vinayak S; University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, 15. AstraZeneca, Seattle, WA, USA.; Hodgson DR; AstraZeneca, Cambridge, UK.; Lai Z; AstraZeneca, Boston, MA, USA.; Dearden S; AstraZeneca, Cambridge, UK.; Hennessy BT; Royal College of Surgeons in Ireland, Dublin, Ireland.; Mayer EL; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Mills GB; Oregon Health & Science University, Portland, OR, USA.; Slavin TP; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA.; Gutin A; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA.; Connolly RM; Cancer Research @UCC, University College Cork, Cork, Ireland.; Telli ML; Stanford University School of Medicine, Stanford, CA, USA.; Stearns V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Lanchbury JS; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA.; Timms KM; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA. ktimms@myriad.com.

Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Haddad TC; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Suman VJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.; D'Assoro AB; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Carter JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.; Giridhar KV; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; McMenomy BP; Department of Radiology, Mayo Clinic, Rochester, Minnesota.; Santo K; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.; Mayer EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Karuturi MS; Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, Texas.; Morikawa A; Department of Medicine, University of Michigan, Ann Arbor.; Marcom PK; Department of Medicine, Duke University Cancer Institute, Durham, North Carolina.; Isaacs CJ; Department of Medicine, Georgetown University, Washington, DC.; Oh SY; Department of Medical Oncology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.; Clark AS; Department of Medicine, University of Pennsylvania, Philadelphia.; Mayer IA; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; Keyomarsi K; Department of Experimental Radiation Oncology, MD Anderson Cancer Center, Houston, Texas.; Hobday TJ; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Peethambaram PP; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; O'Sullivan CC; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Leon-Ferre RA; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Liu MC; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Ingle JN; Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Goetz MP; Department of Oncology, Mayo Clinic, Rochester, Minnesota.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: sara_tolaney@dfci.harvard.edu.; Tarantino P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; European Institute of Oncology IRCCS, Milan, Italy.; Graham N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Tayob N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Parè L; Reveal Genomics, Barcelona, Spain.; Villacampa G; Reveal Genomics, Barcelona, Spain.; Dang CT; Solid Tumor Division, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Yardley DA; Department of Medical Oncology, Sarah Cannon Cancer Center, Nashville, TN, USA.; Moy B; Department of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Marcom PK; Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham, NC, USA.; Albain KS; Department of Medicine, Division of Hematology-Oncology, Loyola University Medical Center, Maywood, IL, USA.; Rugo HS; Department of Medicine, Division of Oncology, University of California, San Francisco, CA, USA.; Ellis MJ; Baylor Clinic Lester and Sue Smith Breast Center, Houston, TX, USA.; Shapira I; Regional Cancer Care Associates, New Hyde Park, New York, NY, USA.; Wolff AC; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.; Carey LA; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA.; Barroso-Sousa R; DASA Oncology, Brasilia Hospital, Diagnósticos da América SA (DASA), Brasília, Brazil.; Villagrasa P; Reveal Genomics, Barcelona, Spain.; DeMeo M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; DiLullo M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Zanudo JGT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute of MIT and Harvard, Boston, MA, USA.; Weiss J; Broad Institute of MIT and Harvard, Boston, MA, USA.; Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Boston, MA, USA.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Waks AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Hudis CA; Solid Tumor Division, Memorial Sloan Kettering Cancer Center, New York, NY, USA; American Society of Clinical Oncology, Alexandria, VA, USA.; Krop IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Yale Cancer Center, New Haven, CT, USA.; Burstein HJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Prat A; Reveal Genomics, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain.; Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Yale Cancer Center, New Haven, CT, USA.

Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Garcia-Recio S; University of North Carolina, Chapel Hill, NC, USA.; Hinoue T; Van Andel Institute, Grand Rapids, MI, USA.; Wheeler GL; Nationwide Children's Hospital, Columbus, OH, USA.; Kelly BJ; Nationwide Children's Hospital, Columbus, OH, USA.; Garrido-Castro AC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Pascual T; University of North Carolina, Chapel Hill, NC, USA.; SOLTI Cancer Research Group, Barcelona, Spain.; De Cubas AA; Vanderbilt University Medical Center, Nashville, TN, USA.; Medical University of South Carolina, Charleston, SC, USA.; Xia Y; University of North Carolina, Chapel Hill, NC, USA.; Boehringer Ingelheim, Ridgefield, CT, USA.; Felsheim BM; University of North Carolina, Chapel Hill, NC, USA.; McClure MB; University of North Carolina, Chapel Hill, NC, USA.; Johns Hopkins University, Baltimore, MD, USA.; Rajkovic A; Nationwide Children's Hospital, Columbus, OH, USA.; Karaesmen E; Nationwide Children's Hospital, Columbus, OH, USA.; Smith MA; University of North Carolina, Chapel Hill, NC, USA.; Fan C; University of North Carolina, Chapel Hill, NC, USA.; Ericsson PIG; Vanderbilt University Medical Center, Nashville, TN, USA.; Sanders ME; Vanderbilt University Medical Center, Nashville, TN, USA.; Creighton CJ; Baylor College of Medicine, Houston, TX, USA.; Bowen J; Nationwide Children's Hospital, Columbus, OH, USA.; Leraas K; Nationwide Children's Hospital, Columbus, OH, USA.; Burns RT; Translational Breast Cancer Research Consortium, Baltimore, USA.; Coppens S; Nationwide Children's Hospital, Columbus, OH, USA.; Wheless A; University of North Carolina, Chapel Hill, NC, USA.; Rezk S; University of North Carolina, Chapel Hill, NC, USA.; Garrett AL; University of North Carolina, Chapel Hill, NC, USA.; Parker JS; University of North Carolina, Chapel Hill, NC, USA.; Foy KK; Van Andel Institute, Grand Rapids, MI, USA.; Shen H; Van Andel Institute, Grand Rapids, MI, USA.; Park BH; Vanderbilt University Medical Center, Nashville, TN, USA.; Krop I; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Anders C; Duke University, Durham, NC, USA.; Gastier-Foster J; Nationwide Children's Hospital, Columbus, OH, USA.; Rimawi MF; Baylor College of Medicine, Houston, TX, USA.; Nanda R; University of Chicago, Chicago, IL, USA.; Lin NU; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Isaacs C; Georgetown University, Washington, DC, USA.; Marcom PK; Duke University, Durham, NC, USA.; Storniolo AM; Indiana University School of Medicine, Indianapolis, IN, USA.; Couch FJ; Mayo Clinic, Rochester, MN, USA.; Chandran U; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Davis M; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Silverstein J; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Ropelewski A; Pittsburgh Supercomputing Center, Carnegie Mellon University, Pittsburgh, PA, USA.; Liu MC; Mayo Clinic, Rochester, MN, USA.; Hilsenbeck SG; Baylor College of Medicine, Houston, TX, USA.; Norton L; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Richardson AL; Johns Hopkins University, Baltimore, MD, USA.; Symmans WF; MD Anderson Cancer Center, Houston, TX, USA.; Wolff AC; Johns Hopkins University, Baltimore, MD, USA.; Davidson NE; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA.; Carey LA; University of North Carolina, Chapel Hill, NC, USA.; Lee AV; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Balko JM; Vanderbilt University Medical Center, Nashville, TN, USA.; Hoadley KA; University of North Carolina, Chapel Hill, NC, USA.; Laird PW; Van Andel Institute, Grand Rapids, MI, USA.; Mardis ER; Nationwide Children's Hospital, Columbus, OH, USA.; King TA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Division of Breast Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Perou CM; University of North Carolina, Chapel Hill, NC, USA. cperou@med.unc.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

Smith CEP; Boston University School of Medicine, Boston Medical Center, 820 Harrison Ave, FGH 1010, Boston, MA, 02118, USA.; Marcom PK; Duke Cancer Center, Duke University Hospital, Durham, NC, USA.; Mitri Z; Oregon Health and Science University, Portland, OR, USA.; Ko NY; Boston University School of Medicine, Boston Medical Center, 820 Harrison Ave, FGH 1010, Boston, MA, 02118, USA. naomi.ko@bmc.org.

Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Ma CX; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.; Siteman Cancer Center, St. Louis, Missouri.; Luo J; Siteman Cancer Center, St. Louis, Missouri.; Division of Public Health Science, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.; Freedman RA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Pluard TJ; Saint Luke's Cancer Institute, Kansas City, Missouri.; Nangia JR; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Lu J; University of Southern California, Los Angeles, California.; Valdez-Albini F; University of Miami, Coral Gables, Florida.; Cobleigh M; Rush University Medical Center, Chicago, Illinois.; Jones JM; Avera Cancer Institute, Sioux Falls, South Dakota.; Lin NU; Dana-Farber Cancer Institute, Boston, Massachusetts.; Winer EP; Dana-Farber Cancer Institute, Boston, Massachusetts.; Marcom PK; Duke Cancer Institute, Durham, North Carolina.; Thomas S; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.; Anderson J; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.; Haas B; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.; Bucheit L; Guardant Health Inc, Redwood City, California.; Bryce R; Puma Biotechnology, Los Angeles, California.; Lalani AS; Puma Biotechnology, Los Angeles, California.; Carey LA; University of North Carolina, Chapel Hill, North Carolina.; Goetz MP; Mayo Clinic, Rochester, Minnesota.; Gao F; Siteman Cancer Center, St. Louis, Missouri.; Division of Public Health Science, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.; Kimmick G; Duke Cancer Institute, Durham, North Carolina.; Pegram MD; Stanford University School of Medicine, Stanford, California.; Ellis MJ; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Bose R; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.; Siteman Cancer Center, St. Louis, Missouri.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Ellis MJ; Suman VJ; Hoog J; Lin L; Snider J; Prat A; Parker JS; Luo J; Deschryver K; Allred DC; Esserman LJ; Unzeitig GW; Margenthaler J; Babiera GV; Marcom PK; Guenther JM; Watson MA; Leitch M; Hunt K; Olson JA

Journal of Clinical Oncology; 6/10/2011, Vol. 29 Issue 17, p2342-2349, 8p

Rumble ME; Keefe FJ; Edinger JD; Affleck G; Marcom PK; Shaw HS

Sleep; 2010 Nov 1, Vol. 33 Issue 11, p1501-1509, 9p